AVEO Oncology Announces Updated NCCN Clinical Practice Guidelines Elevate FOTIVDA®…
BOSTON, June 21, 2022 (GLOBE NEWSWIRE) -- AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company, today announced the National Comprehensive Cancer…